Boston, Massachusetts Est. 2004
Boston skyline

A Boston firm investing in B2B technology, healthcare, and commercial real estate.

Typical initial check size of $60K.

Expect follow-on investments up to $200K.

Clairemont Venture Partners combines long-term family capital with operating perspective, strategic guidance, and investor network access.

50
Active investments
16
Exits since '04
3
Partners

Companies we've backed

Portfolio

Healthcare

12 companies

  • Akston Biosciences
  • Brixton Biosciences
  • Clerio Vision
  • Droplette
  • Eleos Health
  • Eye Cool Therapeutics
  • GEM Health
  • Huma Therapeutics
  • Infobionic
  • IO Health Technologies
  • N1 Health
  • Pirouette Medical

Technology

20 companies

  • Almond Fintech
  • American Ag Energy
  • CLIPr
  • Colaj
  • Databento
  • First Touch
  • Gander Robotics
  • ImageRights
  • Own Up
  • PredictAP
  • Rilla
  • Shibumi
  • SimplyWise
  • Starpath Robotics
  • Sydecar
  • TaxNow
  • Telepathy Labs
  • TireTutor
  • Treasury Prime
  • Wevo

Venture & PE

  • A Squared Ventures Fund II
  • Baukunst
  • Broom Ventures Fund II
  • Coalition Fund II
  • Data Point Capital III
  • Deciens Funds 2020 and 2023
  • Equity Resource Investment 2022
  • Indicator Ventures I, II, III, and IV
  • Two Lanterns

Real Estate (Direct Investments)

  • 1515 Commonwealth Ave, Boston
  • 2177 Brevard, Asheville NC
  • C-Port Fund, Knoxville, TN
  • Cambridge Street, Cambridge
  • Elm Street, Somerville
  • Gould Street, Needham
  • Portland, ME
  • Station Street, Brookline

The Clairemont Venture Partners Team

Bruce Stangle

Bruce Stangle

Strategy, Economics, Healthcare & Investor

Co-Founder of Analysis Group; longstanding angel investor and advisor.

Bates College, MIT Sloan SM, PhD.

LinkedIn →
Alex Stangle

Alex Stangle

Finance & Real Estate

Finance and real estate background; Managing Director, Arbor Realty Trust.

Union College, Babson MBA

LinkedIn →
Derek Stangle

Derek Stangle

Marketing, GTM & SaaS Growth

Senior marketing and go-to-market strategy experience at VistaPrint, Toast, Squadle, Contractbook, and RightCapital.

Union College, MIT Sloan MBA

LinkedIn →

What we bring to the table

  • Strategic Advice

    Business model, market positioning, pricing, growth strategy, and fundraising milestones.

  • Fundraising Support

    Introductions to angels, venture funds, strategic investors, and extended investor networks.

  • Operating Perspective

    Experience in economics, finance, healthcare strategy, real estate, marketing, GTM, and SaaS growth.

  • Patient Capital

    A practical understanding of early-stage volatility and willingness to support companies over time.

What we look for

  1. Exceptional Founders

    Integrity, domain knowledge, resilience, coachability, and the ability to attract talent and capital.

  2. Attractive Market

    A large, growing, or underserved market with a clear customer pain point.

  3. Differentiation

    A technology, data, workflow, network, regulatory, distribution, or business-model advantage.

  4. Traction

    Revenue, pilots, engagement, partnerships, technical validation, or other evidence of demand.

  5. Capital Efficiency

    Credible use of seed capital to reach the next financing, milestone, or sustainable growth path.

  6. Reasonable Valuation

    Typically targeting pre-money valuations in the $5M to $10M range, depending on stage.

Best-fit situations

Where we can add value

Clairemont is most effective when its experience, judgment, and network can materially improve a company's chances of reaching its next milestone.

§ Get in touch

Have a new venture idea?

Or email us directly — hello@clairemontventurepartners.com